My "epidemic of war"
Release time:
2020-07-22
My "War Epidemic "
5# August 10 , three days before I returned to Guizhou Peak after my internship, I was ill.
I felt uncomfortable on the night shift. I thought it would be good to sleep, but it became more and more serious. my temperature soared to 38.6 ℃ ! What a terrible thing this is at this extraordinary time! Although I know very well in my heart that medicine is now so advanced that even if I hit the new coronavirus, it can be cured, but all the news I have experienced and heard about the global "epidemic " over the past few months, it is impossible to say that there is no pressure. Not afraid of your jokes, when I saw the numbers on the thermometer, the first sentence that came to my mind was, "Chen Xiaomin, aged 23 " .
Colleague Zhang Jie also had the same symptoms as me. She cried. She is a mother, a wife and a daughter, so she worries a lot. I understand her mood very well, but am I not the same myself? I think I am strong enough to pretend to be calm and calm, but I am so flustered that I dare not tell my family for fear that they are worried. Looking at the phone calls from colleagues and family members one by one, my heart was empty, as if I had no relatives around me. After sorting out the mood, I finally couldn't help calling home and chatting. Tears poured up and I couldn't stop sobbing. During the internship has been trying to overcome the unaccustomed life, but also suddenly burst out, let me very homesick. From the beginning of the internship, I was looking forward to going home, and finally I was almost there, but there was such a problem. I was so afraid that I couldn't go home.
I Baidu a lot of information, high fever does not subside, diarrhea, dry cough and fever, these are consistent with the new crown symptoms. And our situation has also attracted everyone's attention. For a while, not only Daye Peak was extremely nervous, but it was quickly disinfected. Even the leaders of Guizhou Peak hundreds of kilometers away were alarmed. Colleagues Orchid and Xiaolong returned to the dormitory for isolation. Zhang Jie and I were admitted to the hospital. To be honest, I am not afraid of being infected with the new coronavirus. What puts pressure on me is more physical and mental discomfort. I am afraid of pain, afraid of everyone's resistance to us, afraid of being blamed for bringing the virus to others, afraid of relatives afraid of seeing us ...... Because of all this fear, I can finally truly understand the feelings of the new coronary pneumonia patients. Many things cannot be expressed in words. You have to experience them yourself.
On the first day of admission, I was very tossed. My body temperature dropped and rose, and I was checked by the doctor again. I couldn't sleep all night. Looking at the empty room, I couldn't help feeling scared, so I got up and wiped all the places that the medical alcohol handle in the corridor often touched. Lying on the bed, the quilt is very thick, hot, and dare not kick away, although the clothes have been soaked with sweat, also dare not. I don't want to inconvenience others. Although wearing a mask is very sultry, I have to wear it even if I sleep in my room. When the nurse changed medicine to measure her temperature, I also tried not to touch her and left her some space. The days of hospitalization were really hard, counting the seconds. On the evening of
11 , Zhang Jie's fever completely subsided and her physical condition was normal, while I was still over 38 degrees, and my mood was absolutely terrible. I'm afraid I won't get better, I'm afraid I'll still be in the hospital after she's out of the hospital, and even more afraid, maybe I really got a new crown? Finally, the final test results came out, the nucleic acid test results showed negative, I couldn't help but cry with joy, holding the phone to reply to everyone's messages one by one. Talking to colleagues about "Chen Xiaomin died at 23 " made everyone burst into laughter, and I couldn't help laughing. Yes, I just want to make everyone laugh, relieve the tension these days, and celebrate that everyone can go home together after discharge.
Although it was only a false alarm, I cannot forget that when Master Beijie learned that I had a fever, she immediately called her husband to send me a thermometer. During the hospitalization, the leaders, colleagues and teachers of Daye Peak and Guizhou Peak were worried about our bad food, our unaccustomed life, and gave us food and daily necessities, every day many times to ask our situation ...... these information are too much to reply, I really feel the warmth of home.
's internship in daye peak is a very rare learning opportunity. after this special "war epidemic " , I have deeply imprinted all the stories that happened here in my mind and believe that I will never forget them in my life. Here, I feel the warmth of the spike family. When I needed comfort and help most, it was the spikes that gave me spiritual comfort and moved me much. I'm going to say "Thank you " to all the spikes.
Because of this experience, I also have a special feeling about the new crown epidemic. I sincerely hope that this disaster will end soon, and I believe that as long as we unite as one, we will be able to defeat the new coronavirus and reappear a healthy and beautiful China. Come on, China! (chen xiaomin)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31